Recruiting Retinitis Pigmentosa Studies in Beijing
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
The goal of this clinical trial is to learn if AP301 could work in the patients receiving maintenance dialysis with elevated blood phosphate. The main questions it aims to answer are: * Does AP301 lo...
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
Thrombotic thrombocytopenic purpura (or TTP for short) is a condition where blood clots form in small blood vessels throughout the body. The clots can limit or block the flow of oxygen-rich blood to t...
About Retinitis Pigmentosa Clinical Trials in Beijing
Retinitis pigmentosa (RP) is a group of inherited retinal diseases that cause progressive loss of photoreceptor cells in the retina, leading to vision loss. It typically begins with night blindness and progresses to tunnel vision. Gene therapy and retinal implants are areas of active research.
There are currently 2 retinitis pigmentosa clinical trials recruiting participants in Beijing, BEIJING%20MUNICIPALITY. These studies are seeking a combined 341 participants. Research is being sponsored by Alebund Pharmaceuticals, Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Retinitis Pigmentosa Clinical Trials in Beijing — FAQ
Are there retinitis pigmentosa clinical trials in Beijing?
Yes, there are 2 retinitis pigmentosa clinical trials currently recruiting in Beijing, BEIJING%20MUNICIPALITY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Beijing?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Beijing research site will contact you about next steps.
Are clinical trials in Beijing free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Beijing studies also compensate for your time and travel.
What retinitis pigmentosa treatments are being tested?
The 2 active trials in Beijing are testing new therapies including novel drugs, biologics, and treatment approaches for retinitis pigmentosa.
Data updated March 2, 2026 from ClinicalTrials.gov